ScholarIQanswers from OpenAlex & ORCID
Antoine Tabarin
ResearcherPublications, citations & collaboration network
Antoine Tabarin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Antoine Tabarin have?
ScholarIQindexed works
Antoine Tabarin has 458 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Antoine Tabarin have?
ScholarIQcitation count
Antoine Tabarin has 19,213 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Antoine Tabarin?
ScholarIQh-index
Antoine Tabarin has an h-index of 72 in OpenAlex.
What is the i10-index of Antoine Tabarin?
ScholarIQi10-index
Antoine Tabarin has an i10-index of 181 in OpenAlex.
What is the ORCID of Antoine Tabarin?
ScholarIQorcid
The ORCID for Antoine Tabarin is on the source record.
What is the OpenAlex record for Antoine Tabarin?
ScholarIQopenalex
The OpenAlex for Antoine Tabarin is on the source record.
What are the most-cited papers on Antoine Tabarin?
ScholarIQmost cited works
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
Martin Faßnacht, Wiebke Arlt, Irina Bancos, Henning Dralle, John Newell‐Price, Anju Sahdev, Antoine Tabarin, Massimo Terzolo, Stylianos Tsagarakis, Olaf M Dekkers
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Faßnacht, Stylianos Tsagarakis, Massimo Terzolo, Antoine Tabarin, Anju Sahdev, John Newell‐Price, Iris C. M. Pelsma, Ljiljana Marina, Kerstin Lorenz, Irina Bancos, Wiebke Arlt, Olaf M Dekkers
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian Daly, María A. Tichomirowa, Patrick Pétrossians, Elina Heliövaara, Marie‐Lise Jaffrain‐Rea, Anne Barlier, Luciana Ansaneli Naves, Tapani Ebeling, Auli Karhu, Antti Raappana, Laure Cazabat, Ernesto De Menis, Carmen Fajardo Montañana, Gérald Raverot, Robert J. Weil, Timo Sane, Dominique Maiter, Sebastian Neggers, Maria Yaneva, Antoine Tabarin, Elisa Verrua, Eija Eloranta, Arnaud Murat, Outi Vierimaa, Pasi Salmela, Philippe Émy, Rodrigo A. Toledo, Maria Sabaté, Chiara Villa, Marc Popelier, Roberto Salvatori, Juliet Jennings, A Ferrández Longás, José Ignacio Labarta Aizpún, Marianthi Georgitsi, Ralf Paschke, Cristina L. Ronchi, Matti Välimäki, Carola Saloranta, Wouter W. de Herder, Renato Cozzi, Mirtha Guitelman, Flavia Magri, Maria Stefania Lagonigro, Georges Halaby, Vinciane Corman, Marie-Thérèse Hagelstein, Jean-François Vanbellinghen, Gustavo Barcelos Barra, Anne‐Paule Gimenez‐Roqueplo, Fergus Cameron, Françoise Borson‐Chazot, I. M. Holdaway, S. P. A. Toledo, Günter K. Stalla, Anna Spada, Sabina Zacharieva, Jérôme Bertherat, Thierry Brue, Vincent Bours, Philippe Chanson, Lauri A. Aaltonen, Albert Beckers
Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients
Pierre Goudet, Arnaud Murat, Christine Binquet, C. Cardot‐Bauters, Annie Costa, Philippe Ruszniewski, Patricia Niccoli, Fabrice Mènégaux, G Chabrier, Françoise Borson‐Chazot, Antoine Tabarin, Philippe Bouchard, Brigitte Delemer, Alfred Beckers, Claire Bonithon‐Kopp